semaglutide monthly depot (CAM2056) / Camurus - LARVOL DELTA

Camurus reports positive topline results for CAM2056, semaglutide monthly depot (PRNewswire) - "CAM2056 achieved a similar maximum plasma concentration (Cmax) at a four times higher monthly dose compared to weekly semaglutide. Additionally, CAM2056 showed longer time to Cmax and an extended-release profile suitable for monthly dosing; CAM2056 provided dose-dependent reductions in body weight, A1c and fasting glucose, comparable to or exceeding those with weekly semaglutide to end of treatment, Day 85....The mean A1c change from baseline to Day 85 was -0.44%, after the last 10 mg dose. The treatment difference between CAM2056 and weekly semaglutide was -0.32% (-0.50%, -0.14%)..."

P1 data • Obesity